vs
GCM Grosvenor Inc.（GCMG）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是GCM Grosvenor Inc.的1.1倍（$197.9M vs $177.1M），GCM Grosvenor Inc.净利率更高（32.8% vs 6.7%，领先26.1%），REPLIGEN CORP同比增速更快（13.6% vs 7.2%），GCM Grosvenor Inc.自由现金流更多（$175.0M vs $17.6M），过去两年GCM Grosvenor Inc.的营收复合增速更高（27.5% vs 14.4%）
GCM Grosvenor是美国头部另类资产管理机构，截至2023年资产管理规模约760亿美元，拥有约530名专业人士，为全球机构及个人投资者提供定制化另类投资解决方案，覆盖私募股权、对冲基金、房地产、基础设施等多元资产类别。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
GCMG vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.1倍
$177.1M
营收增速更快
RGEN
高出6.5%
7.2%
净利率更高
GCMG
高出26.1%
6.7%
自由现金流更多
GCMG
多$157.5M
$17.6M
两年增速更快
GCMG
近两年复合增速
14.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $177.1M | $197.9M |
| 净利润 | $58.2M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 30.9% | 9.0% |
| 净利率 | 32.8% | 6.7% |
| 营收同比 | 7.2% | 13.6% |
| 净利润同比 | 149.2% | 143.9% |
| 每股收益（稀释后） | $0.23 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GCMGRGEN
| Q4 25 | $177.1M | $197.9M | ||
| Q3 25 | $135.0M | $188.8M | ||
| Q2 25 | $119.7M | $182.4M | ||
| Q1 25 | $125.8M | $169.2M | ||
| Q4 24 | $165.3M | $174.1M | ||
| Q3 24 | $122.9M | $154.9M | ||
| Q2 24 | $117.0M | $154.1M | ||
| Q1 24 | $108.9M | $151.3M |
净利润GCMGRGEN
| Q4 25 | $58.2M | $13.3M | ||
| Q3 25 | $10.5M | $14.9M | ||
| Q2 25 | $15.4M | $14.9M | ||
| Q1 25 | $463.0K | $5.8M | ||
| Q4 24 | $7.6M | $-30.3M | ||
| Q3 24 | $4.2M | $-654.0K | ||
| Q2 24 | $4.8M | $3.3M | ||
| Q1 24 | $2.1M | $2.1M |
毛利率GCMGRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率GCMGRGEN
| Q4 25 | 30.9% | 9.0% | ||
| Q3 25 | 32.7% | 8.9% | ||
| Q2 25 | 16.1% | 7.6% | ||
| Q1 25 | 12.2% | 3.9% | ||
| Q4 24 | 26.4% | -17.7% | ||
| Q3 24 | 20.3% | -5.1% | ||
| Q2 24 | 17.8% | 1.0% | ||
| Q1 24 | -14.7% | 1.3% |
净利率GCMGRGEN
| Q4 25 | 32.8% | 6.7% | ||
| Q3 25 | 7.8% | 7.9% | ||
| Q2 25 | 12.9% | 8.2% | ||
| Q1 25 | 0.4% | 3.4% | ||
| Q4 24 | 4.6% | -17.4% | ||
| Q3 24 | 3.4% | -0.4% | ||
| Q2 24 | 4.1% | 2.2% | ||
| Q1 24 | 2.0% | 1.4% |
每股收益（稀释后）GCMGRGEN
| Q4 25 | $0.23 | $0.24 | ||
| Q3 25 | $0.16 | $0.26 | ||
| Q2 25 | $0.05 | $0.26 | ||
| Q1 25 | $-0.02 | $0.10 | ||
| Q4 24 | $0.09 | $-0.55 | ||
| Q3 24 | $0.03 | $-0.01 | ||
| Q2 24 | $0.04 | $0.06 | ||
| Q1 24 | $-0.13 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $242.1M | $767.6M |
| 总债务越低越好 | $428.4M | $542.2M |
| 股东权益账面价值 | $27.0M | $2.1B |
| 总资产 | $813.8M | $2.9B |
| 负债/权益比越低杠杆越低 | 15.87× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资GCMGRGEN
| Q4 25 | $242.1M | $767.6M | ||
| Q3 25 | $182.7M | $748.7M | ||
| Q2 25 | $136.3M | $708.9M | ||
| Q1 25 | $94.5M | $697.2M | ||
| Q4 24 | $89.5M | $757.4M | ||
| Q3 24 | $98.4M | $784.0M | ||
| Q2 24 | $73.9M | $809.1M | ||
| Q1 24 | $41.9M | $780.6M |
总债务GCMGRGEN
| Q4 25 | $428.4M | $542.2M | ||
| Q3 25 | $429.3M | $537.9M | ||
| Q2 25 | $430.2M | — | ||
| Q1 25 | $431.1M | — | ||
| Q4 24 | $432.0M | $525.6M | ||
| Q3 24 | $432.9M | — | ||
| Q2 24 | $433.8M | — | ||
| Q1 24 | $384.0M | — |
股东权益GCMGRGEN
| Q4 25 | $27.0M | $2.1B | ||
| Q3 25 | $-7.4M | $2.1B | ||
| Q2 25 | $-12.3M | $2.1B | ||
| Q1 25 | $-28.3M | $2.0B | ||
| Q4 24 | $-27.6M | $2.0B | ||
| Q3 24 | $-31.9M | $2.0B | ||
| Q2 24 | $-28.5M | $2.0B | ||
| Q1 24 | $-26.4M | $2.0B |
总资产GCMGRGEN
| Q4 25 | $813.8M | $2.9B | ||
| Q3 25 | $685.9M | $2.9B | ||
| Q2 25 | $636.9M | $2.9B | ||
| Q1 25 | $579.8M | $2.9B | ||
| Q4 24 | $612.7M | $2.8B | ||
| Q3 24 | $575.0M | $2.8B | ||
| Q2 24 | $543.9M | $2.9B | ||
| Q1 24 | $497.3M | $2.8B |
负债/权益比GCMGRGEN
| Q4 25 | 15.87× | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.5M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $175.0M | $17.6M |
| 自由现金流率自由现金流/营收 | 98.8% | 8.9% |
| 资本支出强度资本支出/营收 | 4.8% | 4.1% |
| 现金转化率经营现金流/净利润 | 3.16× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $326.2M | $93.9M |
8季度趋势，按日历期对齐
经营现金流GCMGRGEN
| Q4 25 | $183.5M | $25.7M | ||
| Q3 25 | $79.8M | $48.1M | ||
| Q2 25 | $42.0M | $28.6M | ||
| Q1 25 | $33.3M | $15.0M | ||
| Q4 24 | $148.8M | $39.2M | ||
| Q3 24 | $69.0M | $49.3M | ||
| Q2 24 | $17.5M | $42.2M | ||
| Q1 24 | $24.2M | $44.7M |
自由现金流GCMGRGEN
| Q4 25 | $175.0M | $17.6M | ||
| Q3 25 | $78.3M | $43.4M | ||
| Q2 25 | $40.8M | $21.5M | ||
| Q1 25 | $32.1M | $11.4M | ||
| Q4 24 | $132.0M | $33.6M | ||
| Q3 24 | $62.2M | $42.3M | ||
| Q2 24 | $12.8M | $37.4M | ||
| Q1 24 | $20.0M | $36.4M |
自由现金流率GCMGRGEN
| Q4 25 | 98.8% | 8.9% | ||
| Q3 25 | 58.0% | 23.0% | ||
| Q2 25 | 34.1% | 11.8% | ||
| Q1 25 | 25.5% | 6.8% | ||
| Q4 24 | 79.9% | 19.3% | ||
| Q3 24 | 50.6% | 27.3% | ||
| Q2 24 | 10.9% | 24.3% | ||
| Q1 24 | 18.4% | 24.0% |
资本支出强度GCMGRGEN
| Q4 25 | 4.8% | 4.1% | ||
| Q3 25 | 1.1% | 2.5% | ||
| Q2 25 | 1.0% | 3.9% | ||
| Q1 25 | 0.9% | 2.1% | ||
| Q4 24 | 10.1% | 3.2% | ||
| Q3 24 | 5.5% | 4.5% | ||
| Q2 24 | 4.0% | 3.1% | ||
| Q1 24 | 3.9% | 5.5% |
现金转化率GCMGRGEN
| Q4 25 | 3.16× | 1.93× | ||
| Q3 25 | 7.61× | 3.23× | ||
| Q2 25 | 2.72× | 1.92× | ||
| Q1 25 | 71.84× | 2.57× | ||
| Q4 24 | 19.54× | — | ||
| Q3 24 | 16.60× | — | ||
| Q2 24 | 3.64× | 12.70× | ||
| Q1 24 | 11.40× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GCMG
| Asset Management1 | $108.6M | 61% |
| Management Service Incentive Performance Fees | $61.7M | 35% |
| Management Service Incentive Carried Interest | $5.1M | 3% |
| Service Other | $1.8M | 1% |
RGEN
暂无分部数据
